Maftouh M - Search Results

1

AKT1 and SELP polymorphisms predict the risk of developing cachexia in pancreatic cancer patients.

Avan A, Avan A, Le Large TY, Mambrini A, Funel N, Maftouh M, Ghayour-Mobarhan M, Cantore M, Boggi U, Peters GJ, Pacetti P, Giovannetti E. Avan A, et al. Among authors: maftouh m. PLoS One. 2014 Sep 19;9(9):e108057. doi: 10.1371/journal.pone.0108057. eCollection 2014. PLoS One. 2014. PMID: 25238546 Free PMC article.

2

Phospho-Akt overexpression is prognostic and can be used to tailor the synergistic interaction of Akt inhibitors with gemcitabine in pancreatic cancer.

Massihnia D, Avan A, Funel N, Maftouh M, van Krieken A, Granchi C, Raktoe R, Boggi U, Aicher B, Minutolo F, Russo A, Leon LG, Peters GJ, Giovannetti E. Massihnia D, et al. Among authors: maftouh m. J Hematol Oncol. 2017 Jan 6;10(1):9. doi: 10.1186/s13045-016-0371-1. J Hematol Oncol. 2017. PMID: 28061880 Free PMC article.

3

A polymorphism in the promoter is associated with EZH2 expression but not with outcome in advanced pancreatic cancer patients.

Maftouh M, Avan A, Funel N, Paolicchi E, Vasile E, Pacetti P, Vaccaro V, Faviana P, Campani D, Caponi S, Mambrini A, Boggi U, Cantore M, Milella M, Peters GJ, Reni M, Giovannetti E. Maftouh M, et al. Pharmacogenomics. 2014 Apr;15(5):609-18. doi: 10.2217/pgs.13.225. Pharmacogenomics. 2014. PMID: 24798718

4

MET as a potential target for the treatment of upper gastrointestinal cancers: characterization of novel c-Met inhibitors from bench to bedside.

Avan A, Maftouh M, Funel N, Ghayour-Mobarhan M, Boggi U, Peters GJ, Giovannetti E. Avan A, et al. Among authors: maftouh m. Curr Med Chem. 2014;21(8):975-89. doi: 10.2174/09298673113209990231. Curr Med Chem. 2014. PMID: 23992325 Review.

5

Synergistic interaction of novel lactate dehydrogenase inhibitors with gemcitabine against pancreatic cancer cells in hypoxia.

Maftouh M, Avan A, Sciarrillo R, Granchi C, Leon LG, Rani R, Funel N, Smid K, Honeywell R, Boggi U, Minutolo F, Peters GJ, Giovannetti E. Maftouh M, et al. Br J Cancer. 2014 Jan 7;110(1):172-82. doi: 10.1038/bjc.2013.681. Epub 2013 Oct 31. Br J Cancer. 2014. PMID: 24178759 Free PMC article.

6

Enhancement of the antiproliferative activity of gemcitabine by modulation of c-Met pathway in pancreatic cancer.

Avan A, Quint K, Nicolini F, Funel N, Frampton AE, Maftouh M, Pelliccioni S, Schuurhuis GJ, Peters GJ, Giovannetti E. Avan A, et al. Among authors: maftouh m. Curr Pharm Des. 2013;19(5):940-50. Curr Pharm Des. 2013. PMID: 22973962

7

Molecular mechanisms underlying the role of microRNAs in resistance to epidermal growth factor receptor-targeted agents and novel therapeutic strategies for treatment of non-small-cell lung cancer.

Maftouh M, Avan A, Galvani E, Peters GJ, Giovannetti E. Maftouh M, et al. Crit Rev Oncog. 2013;18(4):317-26. doi: 10.1615/critrevoncog.2013007191. Crit Rev Oncog. 2013. PMID: 23614618 Review.

8

Crizotinib inhibits metabolic inactivation of gemcitabine in c-Met-driven pancreatic carcinoma.

Avan A, Caretti V, Funel N, Galvani E, Maftouh M, Honeywell RJ, Lagerweij T, Van Tellingen O, Campani D, Fuchs D, Verheul HM, Schuurhuis GJ, Boggi U, Peters GJ, Würdinger T, Giovannetti E. Avan A, et al. Among authors: maftouh m. Cancer Res. 2013 Nov 15;73(22):6745-56. doi: 10.1158/0008-5472.CAN-13-0837. Epub 2013 Oct 1. Cancer Res. 2013. PMID: 24085787

9

miR-211 modulates gemcitabine activity through downregulation of ribonucleotide reductase and inhibits the invasive behavior of pancreatic cancer cells.

Maftouh M, Avan A, Funel N, Frampton AE, Fiuji H, Pelliccioni S, Castellano L, Galla V, Peters GJ, Giovannetti E. Maftouh M, et al. Nucleosides Nucleotides Nucleic Acids. 2014;33(4-6):384-93. doi: 10.1080/15257770.2014.891741. Nucleosides Nucleotides Nucleic Acids. 2014. PMID: 24940696

10

Galectin-4 expression is associated with reduced lymph node metastasis and modulation of Wnt/β-catenin signalling in pancreatic adenocarcinoma.

Maftouh M, Belo AI, Avan A, Funel N, Peters GJ, Giovannetti E, Van Die I. Maftouh M, et al. Oncotarget. 2014 Jul 30;5(14):5335-49. doi: 10.18632/oncotarget.2104. Oncotarget. 2014. PMID: 24977327 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

78 results

Search Page